Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p‐tau217 immunoassays is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 78 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: RF1 AG061900
National Institute on Aging
Grant: R01 AG041851
NIA NIH HHS
Grant: P30 AG062677
National Institute on Aging
Grant: U01 AG006786
NIA NIH HHS
Grant: R01 AG056366
NIA NIH HHS
Grant: RF1 AG069052
NIA NIH HHS
Grant: R37 AG011378
National Institutes of Health
Grant: 2U01AG006786-04
ALZHEIMERS DISEASE PATIENT REGISTRY
National Institutes of Health
Grant: 3RF1AG061900-10A1S1
Blood amyloid-beta relationship with amyloid plaques and CSF amyloid-beta
National Institutes of Health
Grant: 5P30AG062677-02
Mayo Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG056366-04
Exceptional Aging: Identifying Modifiers of Alzheimer's Disease Trajectories
National Institutes of Health
Grant: 2R01AG041851-06
Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system
National Institutes of Health
Grant: 1RF1AG069052-01A1
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias
National Institutes of Health
Grant: 5R37AG011378-32
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkers
Fields of Study
MeSH Terms
Keywords